HK33584A - Aromatic derivates of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections - Google Patents

Aromatic derivates of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections

Info

Publication number
HK33584A
HK33584A HK335/84A HK33584A HK33584A HK 33584 A HK33584 A HK 33584A HK 335/84 A HK335/84 A HK 335/84A HK 33584 A HK33584 A HK 33584A HK 33584 A HK33584 A HK 33584A
Authority
HK
Hong Kong
Prior art keywords
derivates
aromatic
processes
preparation
pharmaceutical compositions
Prior art date
Application number
HK335/84A
Other languages
English (en)
Inventor
Helgstrand Ake John Erik
Johansson Karl Nils-Gunnar
Misiorny Alfons
Noren Jan-Olof
Stening Goran Bertil
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of HK33584A publication Critical patent/HK33584A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK335/84A 1977-12-22 1984-04-18 Aromatic derivates of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections HK33584A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB5358277 1977-12-22
GB5358177 1977-12-22
GB5358077 1977-12-22
GB5358377 1977-12-22
GB7828548 1978-07-03
GB7828553 1978-07-03
GB7828555 1978-07-03
GB7828552 1978-07-03

Publications (1)

Publication Number Publication Date
HK33584A true HK33584A (en) 1984-04-27

Family

ID=27571200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK335/84A HK33584A (en) 1977-12-22 1984-04-18 Aromatic derivates of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections

Country Status (14)

Country Link
US (4) US4372894A (da)
EP (2) EP0003007B1 (da)
JP (2) JPS54106431A (da)
AT (1) AT369017B (da)
AU (1) AU530031B2 (da)
CA (2) CA1140049A (da)
DE (2) DE2861045D1 (da)
DK (2) DK148631C (da)
FI (2) FI68626C (da)
HK (1) HK33584A (da)
IE (1) IE48011B1 (da)
MY (1) MY8500058A (da)
NO (2) NO156611C (da)
SG (1) SG82383G (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5166386A (en) * 1989-09-18 1992-11-24 E. R. Squibb & Sons, Inc. Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5132414A (en) * 1990-05-10 1992-07-21 Dana-Farber Cancer Institute, Inc. Dideoxynucleoside-5'-phosphonoformic acid compounds
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
WO1999008685A1 (en) * 1997-08-18 1999-02-25 Queen's University At Kingston Phosphono-carboxylate compounds for treating amyloidosis
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
MXPA00007815A (es) * 1998-02-11 2002-04-24 Neurochem Inc Metodo para modular la activacion de macrofagos.
US6329356B1 (en) * 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
BR0010099A (pt) * 1999-04-28 2002-06-04 Univ Kingston Métodos para modular a agregação de amilóides em um indivìduo, para o tratamento de um estado doentio associado com amiloidose, composição para modular amiloidose, e, métodos para inibir os depósitos de amilóide associados com iapp em um indivìduo, para inibir fibrilogenese iapp em um indivìduo, para reduzir os agregados de amilóides associados com iapp em um indivìduo, para modular dano associado com amilóides em células, e para modular amiloidose in vivo ou ex vivo
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
WO2001085093A2 (en) 1999-12-23 2001-11-15 Neurochem, Inc. Compounds and methods for modulating cerebral amyloid angiopathy
DE60307804T2 (de) * 2002-04-01 2007-01-18 Pfizer Inc. Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US20040214178A1 (en) * 2003-04-24 2004-10-28 Agouron Pharmaceuticals, Inc. Reporter-selectable Hepatitis C virus replicon
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
UA88909C2 (ru) * 2004-08-18 2009-12-10 Пфайзер Инк. Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
EP1817305A2 (en) * 2004-11-16 2007-08-15 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
ES2352801T3 (es) * 2005-12-22 2011-02-23 Kiacta Sàrl Tratamiento de nefropatía diabética.
ES2891278T3 (es) 2006-10-12 2022-01-26 Bhi Lp Métodos, compuestos, composiciones y vehículos para suministrar ácido 3-amino-1-propanosulfónico
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
DE102012103717A1 (de) * 2012-04-27 2013-11-14 Westfälische Wilhelms-Universität Münster Arzneimittel zur Behandlung von Tumorerkrankungen
WO2015093091A1 (ja) * 2013-12-19 2015-06-25 宇部興産株式会社 非水電解液、それを用いた蓄電デバイス、及びそれに用いられるホスホノぎ酸化合物
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN109400645A (zh) * 2017-08-18 2019-03-01 四川海思科制药有限公司 一种磷酸衍生物及制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155597A (en) * 1961-06-23 1964-11-03 Monsanto Co Extractive separation process
US3997544A (en) * 1968-05-24 1976-12-14 E. I. Du Pont De Nemours And Company Plant growth regulant carbamoylphosphonates
US3846512A (en) * 1968-05-24 1974-11-05 Du Pont Carbamoylphosphonates
CH513590A (de) 1968-05-24 1971-10-15 Du Pont Carbamoylphosphonat enthaltender Pflanzenwachstumsregler
US3533995A (en) * 1968-08-27 1970-10-13 Fmc Corp Heat stabilization of polyester resin with alkyl dialkoxyphosphinyl formate
US3849102A (en) * 1969-08-14 1974-11-19 Du Pont Plant growth regulant method
GB1317768A (en) 1969-08-14 1973-05-23 Du Pont Plant growth regulants
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
HU171255B (hu) 1973-07-23 1977-12-28 Du Pont Kompozicii dlja regulirovki rosta rastenijj
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
US4017297A (en) * 1975-08-29 1977-04-12 E. I. Du Pont De Nemours And Company Phosphonates for the control of bindweed
US4092412A (en) * 1976-04-30 1978-05-30 Abbott Laboratories Treatment of herpes simplex infections
CA1069526A (en) * 1976-04-30 1980-01-08 Thomas R. Herrin Phosphorus esters of phosphonoacetic acid
US4052439A (en) * 1976-04-30 1977-10-04 Abbott Laboratories Carboxylic esters of phosphonoacetic acid
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid

Also Published As

Publication number Publication date
JPS6254118B2 (da) 1987-11-13
AU530031B2 (en) 1983-06-30
ATA921778A (de) 1982-04-15
US4536400A (en) 1985-08-20
DE2861045D1 (en) 1981-11-26
IE48011B1 (en) 1984-09-05
NO156611C (no) 1987-10-21
FI65438C (fi) 1984-05-10
DK148632B (da) 1985-08-19
NO154751B (no) 1986-09-08
EP0003007A3 (en) 1979-08-08
NO784331L (no) 1979-06-25
JPS6330885B2 (da) 1988-06-21
DK564278A (da) 1979-06-23
CA1144937A (en) 1983-04-19
AT369017B (de) 1982-11-25
DE2861729D1 (en) 1982-05-19
US4591583A (en) 1986-05-27
FI783931A (fi) 1979-06-23
SG82383G (en) 1985-03-08
US4372894A (en) 1983-02-08
AU4268278A (en) 1979-06-28
IE782493L (en) 1979-06-22
DK148631C (da) 1986-03-03
FI783932A (fi) 1979-06-23
NO154751C (no) 1986-12-17
NO156611B (no) 1987-07-13
NO784330L (no) 1979-06-25
FI68626C (fi) 1985-10-10
CA1140049A (en) 1983-01-25
EP0003275B1 (en) 1981-09-02
DK148631B (da) 1985-08-19
JPS54106431A (en) 1979-08-21
FI65438B (fi) 1984-01-31
MY8500058A (en) 1985-12-31
EP0003275A1 (en) 1979-08-08
DK148632C (da) 1986-03-03
EP0003007A2 (en) 1979-07-11
DK564178A (da) 1979-06-23
EP0003007B1 (en) 1982-04-07
US4386081A (en) 1983-05-31
JPS54109951A (en) 1979-08-29
FI68626B (fi) 1985-06-28

Similar Documents

Publication Publication Date Title
HK33584A (en) Aromatic derivates of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections
DE3072122D1 (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation
MY8700725A (en) O-substituted derivatives of (+)-cyanidan-3-ol, processes for their preparation and pharmaceutical compositions containing these compounds and their preparation
ZA786313B (en) 9-(w-heteroarylamino-alkylamino-erythromycines,their salts,processes for their preparation and pharmaceutical compositions containing them
IL49911A (en) 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
IL49411A0 (en) Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL50047A (en) Somatostatin analogs,their preparation and pharmaceutical compositions containing them
IL59425A (en) Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
IL55254A (en) Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
DE2861646D1 (en) Derivatives of furyl compounds, their preparation and pharmaceutical compositions containing them
IL50062A0 (en) Substituted diphenyl sulfides,their preparation and pharmaceutical compositions containing them
IT1193334B (it) Composti triazinonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IL55427A (en) 2-hydrazonopropionic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
IL56240A0 (en) Novel derivatives of cyclobutenecarboxylic acid, their preparation and insecticidal compositions containing them
IL56167A (en) Antiviral pharmaceutical compositions comprising 8-aminoalkyltetracyclononane derivatives,certain such novel compounds and their preparation
DE2861177D1 (en) 2-benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them
IL50644A (en) 12-aza-11-oxo-15-hydroxyprostanoic acid analogues,their preparation and pharmaceutical compositions containing them
IL57931A0 (en) Derivatives of 6-methoxy-2-acetyl-naphthalene oxime,their preparation and pharmaceutical compositions containing them
DE2860212D1 (en) 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions
DE2861477D1 (en) (omega-aminoalkoxy) bibenzyls, processes for their preparation and pharmaceutical compositions containing these substances
DE2862327D1 (en) Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
DE2860471D1 (en) Derivatives of benzenesulfonamide, method for their preparation and pharmaceutical compositions containing them
IL55229A0 (en) New oxanilic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PE Patent expired